vs
Side-by-side financial comparison of CoastalSouth Bancshares, Inc. (COSO) and Valneva SE (VALN). Click either name above to swap in a different company.
Valneva SE is the larger business by last-quarter revenue ($36.2M vs $21.3M, roughly 1.7× CoastalSouth Bancshares, Inc.). CoastalSouth Bancshares, Inc. runs the higher net margin — 31.7% vs -54.1%, a 85.8% gap on every dollar of revenue.
CoastalSouth Bancshares, Inc. is a U.S.-based regional bank holding company. It provides a full range of personal and commercial banking services including deposit accounts, consumer loans, mortgages, commercial financing and wealth management solutions for retail customers and small-to-medium enterprises across the U.S. Gulf Coast region.
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States.
COSO vs VALN — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2023
| Metric | | |
|---|---|---|
| Revenue | $21.3M | $36.2M |
| Net Profit | $6.7M | $-19.6M |
| Gross Margin | — | 38.9% |
| Operating Margin | 41.2% | -49.5% |
| Net Margin | 31.7% | -54.1% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.54 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $21.3M | — | ||
| Q2 25 | $19.9M | — | ||
| Q1 23 | — | $36.2M | ||
| Q2 22 | — | $93.2M |
| Q3 25 | $6.7M | — | ||
| Q2 25 | $6.0M | — | ||
| Q1 23 | — | $-19.6M | ||
| Q2 22 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 23 | — | 38.9% | ||
| Q2 22 | — | — |
| Q3 25 | 41.2% | — | ||
| Q2 25 | 35.4% | — | ||
| Q1 23 | — | -49.5% | ||
| Q2 22 | — | -161.3% |
| Q3 25 | 31.7% | — | ||
| Q2 25 | 30.0% | — | ||
| Q1 23 | — | -54.1% | ||
| Q2 22 | — | — |
| Q3 25 | $0.54 | — | ||
| Q2 25 | $0.57 | — | ||
| Q1 23 | — | — | ||
| Q2 22 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $250.4M | $221.2M |
| Total Assets | $2.3B | $637.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 23 | — | $274.8M | ||
| Q2 22 | — | $363.1M |
| Q3 25 | $250.4M | — | ||
| Q2 25 | $209.4M | — | ||
| Q1 23 | — | $221.2M | ||
| Q2 22 | — | $100.7M |
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.2B | — | ||
| Q1 23 | — | $637.2M | ||
| Q2 22 | — | $783.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.5M | $-26.3M |
| Free Cash FlowOCF − Capex | $-5.9M | — |
| FCF MarginFCF / Revenue | -27.7% | — |
| Capex IntensityCapex / Revenue | 1.9% | — |
| Cash ConversionOCF / Net Profit | -0.82× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-5.5M | — | ||
| Q2 25 | $-16.8M | — | ||
| Q1 23 | — | $-26.3M | ||
| Q2 22 | — | — |
| Q3 25 | $-5.9M | — | ||
| Q2 25 | $-17.9M | — | ||
| Q1 23 | — | — | ||
| Q2 22 | — | — |
| Q3 25 | -27.7% | — | ||
| Q2 25 | -90.3% | — | ||
| Q1 23 | — | — | ||
| Q2 22 | — | — |
| Q3 25 | 1.9% | — | ||
| Q2 25 | 5.5% | — | ||
| Q1 23 | — | — | ||
| Q2 22 | — | — |
| Q3 25 | -0.82× | — | ||
| Q2 25 | -2.82× | — | ||
| Q1 23 | — | — | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
